Brexpiprazole for schizophrenia and as adjunct for major depressive disorder

Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study

PDF) Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression

Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Phase 3, Randomized, Double-Blind Study

Brexpiprazole Semantic Scholar

Clinical role of brexpiprazole in depression and schizophrenia

Brain Sciences, Free Full-Text

PDF) Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study

Adjunctive Atypical Antipsychotics in Major Depressive Disorder: What's the Impact?

Effects of adjunctive brexpiprazole on patient life engagement in major depressive disorder: Post hoc analysis of Inventory of Depressive Symptomatology Self-Report data - ScienceDirect

Brexpiprazole - wikidoc

Brexpiprazole: Package Insert

Pharmacoeconomic Review Report: Brexpiprazole (Rexulti) - NCBI Bookshelf

The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open

Brexpiprazole for schizophrenia and as adjunct for major depressive disorder